Xeris Pharmaceuticals, Inc. SBIR Phase I Award,
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. for $678,969.0 USD from the U.S. Department of Health & Human Services.
Name
# Contributions
Last Contribution
Find more entities like Xeris Pharmaceuticals, Inc. SBIR Phase I Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.